Filing Flows › SelectQuote (SLQT) › Stock forecast & fair value
SelectQuote (SLQT) stock forecast and fair value
SelectQuote (SLQT) trades at $0.36. 4 analysts' median price target is $2.50 (+600%), from $0.35 to $3.00. Across 6 valuation methods the middle fair value is $3.70 (+936%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| Residual income | $2.42 | $2.51 | $2.60 | +603% |
| P/B vs ROE (insurer peers) | $1.86 | $4.52 | $7.18 | 13× |
| Analysts' price targets | $0.35 | $2.09 | $3.00 | +485% |
| Justified P/B (Gordon growth) | $3.73 | $4.25 | $4.93 | 12× |
| Stage-weighted value (financial (bank / insurer)) | $2.54 | $3.70 | $4.90 | +936% |
| Combined forecast (3 months) | $0.29 | $0.37 | $0.46 | +3% |
SelectQuote's latest quarter
SelectQuote, Q1 FY27: revenue $280M (-15% year over year), operating margin -10.2%, net loss $20.3M, operating cash flow −$17.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for SLQT stock?
The median of 4 analysts' 12-month targets is $2.50, +600% from $0.36; the range is $0.35 to $3.00. The average rating is buy.
What is SelectQuote's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $0.37 and $4.52, with a middle value of $3.70 against a price of $0.36. Each method's assumptions are on the page.
Does SelectQuote usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is SLQT stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.